Table 1 Characteristics of each patient group.

From: Characteristic cerebral structural changes identified using voxel-based morphometry in patients with post-surgical chronic myelopathic pain

Case

Age (y)

Gender

POD

NRS

painDETECT

The modified McCormick scale

Tumor type

Tumor location

 

a. Control patients

         

1

62

M

2771

0

2

III

Ependymoma

C5/6-Th2/3

 

2

44

F

2956

0

0

III

Ependymoma

C2/3-6/7

 

3

52

M

881

0

3

II

Cavernous Hemangioma

C2/3-3/4

 

4

76

M

667

0

6

V

Syringomyelia

Th11/12-Th12/L1

 

5

69

M

849

0

1

II

Hemangioblastoma

C3/4-6/7

 

6

58

M

1819

0

0

III

Ependymoma

C1/2-2/3

 

7

33

M

930

1

0

II

Ependymoma

C0-6

 

8

23

F

1164

1

6

III

Pilocytic Astrocytoma

Th10/11-11/12

 

9

69

M

2599

1

1

II

Intramedullary Neurinoma

C1/2-2/3

 

10

38

F

2312

1

4

II

Ependymoma

Th6/7-Th10/11

 

11

33

M

881

2

8

II

Hemangioblastoma

Th5/6-6/7

 

Mean

50.6

 

1620

0.6

2.8

    

Median

52

 

1164

0

2

    

Range

23–76

 

667–2956

0–2

0–8

    

Case

Age (y)

Gender

POD

NRS

painDETECT

The modified McCormick scale

Tumor type

tumor location

pain location

b. Patients with below level pain

         

1

62

M

1210

3

11

III

Cavernous Hemangioma

Th10-Th12

Lt. S1

2

48

F

1049

4

19

II

Cavernous Hemangioma

Th10/11

Bil. L5

3

53

F

1553

5

18

I

Intramedullary Neurinoma

Th12/L1

Lt. L5

4

60

F

730

5

14

III

Intramedullary Lipoma

C7-Th4

Bil. L5

5

59

M

559

5

15

II

Ependymoma

C3/4-4/5

Lt . C5, 8

6

53

M

1294

5

4

III

Subependymoma

C6/7-Th4/5

Rt. L5

7

59

M

1854

6

16

II

Ependymoma

C4-7

Bil. below Th4

8

73

F

807

7

15

III

Cavernous Hemangioma

C6/7

Bil. below C8

9

62

M

1000

7

17

I

Myxopapillary Ependymoma

C5/6-6/7

Bil. below C8

10

65

M

2095

7

24

II

Ependymoma

C4/5-Th3/4

Bil. below C8

11

69

F

1797

7

25

I

Intramedullary arachnoid cyst

Th9-12

Bil. L5

12

69

F

2449

8

29

IV

Cavernous Hemangioma

C3/4

Bil. below C6

13

65

F

4563

8

21

II

Ependymoma

C4-Th2

Bil. below T4

14

72

M

1869

8

20

III

Ependymoma

C3/4-6/7

Lt. Th8

15

86

M

3502

8

18

II

Arteriovenous fistula

Th8/9

Bil. below L3

16

50

M

568

8.5

14

III

Intramedullary Neurinoma

Th1/2-3/4

Lt. below Th4

17

49

F

3318

9

29

II

Astrocytoma

C5-Th2

Bil. L5

18

77

M

3394

10

23

III

Ependymoma

C2/3-3/4

Bil. below C4

19

31

M

649

10

29

I

Ependymoma

C3/4-C7/Th1

Bil. below Th4

Mean

61.2

 

1804

6.9

19.0

    

Median

62

 

1553

7

18

    

Range

31–86

 

559–4563

3–10

4–29

    

Case

Age (y)

Gender

POD

NRS

painDETECT

The modified McCormick scale

Tumor type

tumor location

pain location

c. Patients without below level pain

         

1

45

M

611

4

10

II

Hemangioblastoma

C4/5-5/6

Rt. C7

2

34

M

2288

4

9

II

Astrocytoma

Th10-Th12

Rt. L5

3

49

F

1231

5

16

III

Cavernous Hemangioma

C4/5

Lt. C6

4

65

F

556

5

17

II

Ependymoma

C6/7-Th1/2

Rt. C8

5

47

M

182

6

18

III

Hemangioblastoma

C1/2

Rt. C6

6

64

M

2498

6

11

II

Ependymoma

Th7-10

Rt Th8

7

65

F

2358

6

17

III

Ependymoma

C5/6.6/7

Lt. C8

8

43

F

2918

6

16

III

Ependymoma

C4/5-5/6

Lt. C6

9

46

F

3474

6

16

I

Syringomyelia

C2/3-Th6/7

Lt. C6

10

65

F

1703

6

10

III

Spinal Cord Herniation

Th5/6

Rt. Th6

11

38

M

1724

7

26

I

Ependymoma

C6/7-Th2/3

Bil. C8

12

70

M

4703

7

20

I

Syringomyelia

C2/3-C7/8

Lt. C8

13

63

F

1297

7

15

III

Subependymoma

C5/6-Th1/2

Lt. Th1

14

42

M

6174

7

12

IV

Astrocytoma

C4-6

Rt. C8

15

54

M

2274

8

19

III

Hemangioblastoma

Th6/7

Lt. C6

16

56

F

4038

8

19

III

Tethered cord syndrome

L4/5

Rt. L5

17

40

M

1448

8

19

I

Ependymoma

C5-Th1

Bil. C8

18

68

F

282

8

18

IV

Hemangioblastoma

Th1-4

Bil. Th4

19

38

M

457

9

14

III

Subependymoma

C7-Th2

Rt. C8

Mean

52.2

 

2117

6.5

15.9

    

Median

49

 

1724

6

17

    

Range

38–70

 

181–4703

4–9

9–26

    
  1. The age, gender, post-operative days (POD), numeric rating scale (NRS), painDETECT, tumor/disease type, tumor location and pain location are shown